UNITED NATIONS | DEPARTMENT OF OPERATIONAL SUPPORT 3
TREATMENT COSTS
How will invoices from treatment facilities be treated?
10. Cigna has been engaged to act as Third-Party Administrator for the administration of medical billing for patients who have been medically evacuated and treated for COVID-19 through the MEDEVAC System.
11. All invoices for all patients treated through the COVID-19 MEDEVAC System will be submitted by
hospitals to Cigna to provide for a streamlined invoicing and payment process. (...) The Letter of Guarantee is a necessary assurance to the medical facility which will receive and treat the medically evacuated patient that invoices will be paid.
13.
Language:English
Score: 1050210.8
-
https://www.un.org/sites/un2.u...ce_-_financingarrangements.pdf
Data Source: un
The Patient Focal Point is responsible for overseeing the non-medical needs of and
making administrative and logistical arrangements for individual COVID-19 patients who
have been medically evacuated to the country and any non-medical escorts. (...) Address all queries regarding administrative and financial issues associated with the associated patient and any non-medical escort, including seeking any required internal authorisations required;
ix. (...) Maintain contact with the Patient Coordination Officer and address any ongoing administrative requirements, and proactively understand the projected recovery timeline of the patient;
vi.
Language:English
Score: 1043453.2
-
https://www.un.org/sites/un2.u...st-medevac_support_process.pdf
Data Source: un
Guinea-Bissau's Long-Lasting Insecticide-treated Net (LLIN) Campaign | United Nations Development Programme
Skip to main content
Guinea-Bissau
Who we are
What we do
Our impact
Get involved
English
Português
Global
Nav toggle
Search
Who we are
What we do
Our impact
Get involved
English
Locations
Back
Select Language
Português
Home
Guinea-Bissau
Guinea-Bissau's Long-Lasting Insecticide-treated Net (LLIN) Campaign
Guinea-Bissau's Long-Lasting Insecticide-treated Net (LLIN) Campaign
April 12, 2021
National campaign to distribute Long-Lasting Insecticide-treated Nets (LLINs) using wheelbarrows to reach the population, Photo: UNDP 2021
In 2020, the Government of Guinea-Bissau, with the support of its partners including UNDP, carried out a national campaign to distribute Long-Lasting Insecticide-treated Nets (LLINs) to the entire population in line with the WHO recommendation of a three-year campaign cycle. (...) This equated to one LLIN for every 1.8 people (provisional administrative data). Strong engagement of all actors involved in the campaign at a time when the state of emergency was declared ensured a rapid strategy review and adaptation to align to the context of COVID-19 and the measures for its prevention put in place by the Government of Guinea-Bissau. Three strategies namely, advocacy, social mobilization and social and behaviour change communication made the results possible. Political, administrative, and religious representatives, NGOs and associations, civil society organizations, media leaders, etc. were involved in all three strategies.
Language:English
Score: 1038936.5
-
https://www.undp.org/guinea-bi...reated-net-llin-campaign%C2%A0
Data Source: un
Center for Veterinary Medicine; United States Food and Drug Administration | Global Feed Safety Platform | Food and Agriculture Organization of the United Nations
FAO.org
english
français
Español
Global Feed Safety Platform
Background
Databases
Resources
Forum
News and Events
Login
Experts and professionals
Organizations and institutions
Center for Veterinary Medicine; United States Food and Drug Administration
Governmental institutions
7519 Standish Place, Rockville, Maryland, USA
[email protected]
240-402-7190
http://www.fda.gov/animalveterinary/default.htm
The mission statement for FDA’s Center for Veterinary Medicine (CVM) reads: “Protecting Human and Animal Health.” (...) If the drug is for a food-producing animal, before approving it, the center also makes sure that food products made from treated animals—meat, milk, and eggs—are safe for people to eat; Monitors the safety and effectiveness of animal drugs on the market; Makes sure food for animals—which includes animal feed, pet food, and pet treats—is safe, made under sanitary conditions, and properly labeled; Makes sure a food additive for use in food for animals is safe and effective before approving it; Conducts research that helps FDA ensure the safety of animal drugs, food for animals, and food products made from animals; and Helps make more animal drugs legally available for minor species, such as fish, hamsters, and parrots; and for minor (infrequent and limited) uses in a major species, such as cattle, turkeys, and dogs.
(...) To that end, the Center for Veterinary Medicine (CVM): monitors and establishes standards for feed contaminants, approves safe food additives, and manages the Food and Drug Administration's (FDA) medicated feed and pet food programs.
Language:English
Score: 1037534.1
-
https://www.fao.org/feed-safet...itutions-details/en/c/1025182/
Data Source: un
During the period when a COVID-19 patient is hospitalised:
a) The medical welfare of the patient will be overseen by the appropriate Treating
Medical Provider (TMP) at the receiving Treating Medical Facility (TMF), in line with any agreed terms of reference.
b) The Patient Coordination Officer will maintain an overview of the status of the
patient and will update the Patient Focal Point, and any non-medical escorts as appropriate.
c) The Patient Coordination Officer will convey any administrative or other non-
medical information or requests made by the Treating Medical Facility to the Patient Focal Point. (...) The Patient Coordination Officer will continue to convey any administrative or financial
queries from the treating medical facility to the Patient Focal Point.
(...) Treating Medical Provider (TMP) –The medical professional directly responsible for providing care for the COVID-19 patient within the Treating Medical Facility or in any subsequent capacity prior to the repatriation of the COVID-19 patient.
Language:English
Score: 1025620.1
-
https://www.un.org/sites/un2.u...-medevac_support_framework.pdf
Data Source: un
Center for Veterinary Medicine; United States Food and Drug Administration | La plataforma global de la inocuidad de los piensos | Organización de las Naciones Unidas para la Alimentación y la Agricultura
FAO.org
english
français
Español
La plataforma global de la inocuidad de los piensos
Antecedentes
Bases de datos
Recursos
Foro
Noticias y eventos
Iniciar sesión
Expertos y profesionales
Organizaciones e instituciones
Center for Veterinary Medicine; United States Food and Drug Administration
Institución gubernamental
7519 Standish Place, Rockville, Maryland, USA
[email protected]
240-402-7190
http://www.fda.gov/animalveterinary/default.htm
The mission statement for FDA’s Center for Veterinary Medicine (CVM) reads: “Protecting Human and Animal Health.” (...) If the drug is for a food-producing animal, before approving it, the center also makes sure that food products made from treated animals—meat, milk, and eggs—are safe for people to eat; Monitors the safety and effectiveness of animal drugs on the market; Makes sure food for animals—which includes animal feed, pet food, and pet treats—is safe, made under sanitary conditions, and properly labeled; Makes sure a food additive for use in food for animals is safe and effective before approving it; Conducts research that helps FDA ensure the safety of animal drugs, food for animals, and food products made from animals; and Helps make more animal drugs legally available for minor species, such as fish, hamsters, and parrots; and for minor (infrequent and limited) uses in a major species, such as cattle, turkeys, and dogs.
(...) To that end, the Center for Veterinary Medicine (CVM): monitors and establishes standards for feed contaminants, approves safe food additives, and manages the Food and Drug Administration's (FDA) medicated feed and pet food programs.
Language:English
Score: 1023728
-
https://www.fao.org/feed-safet...titutionsdetails/es/c/1025182/
Data Source: un
Any information received by a
Contracting State shall be treated as secret in the same manner as information obtained under the domestic laws of the
State. (...) Any information received by a Contracting State shall be treated as secret in the same
manner as information obtained under the domestic laws of that State and shall be disclosed only to persons or
authorities (including courts and administrative bodies) concerned with the assessment or collection of, the
enforcement or prosecution in respect of, or the determination of appeals in relation to the taxes referred to in the
first sentence. (...) Any information received under paragraph 1 by a Contracting State shall be treated as secret in the same manner as
information obtained under the domestic laws of that State and shall be disclosed only to persons or authorities (including
courts and administrative bodies) concerned with the assessment or collection of, the enforcement or prosecution in
respect of, the determination of appeals in relation to the taxes referred to in paragraph 1, or the oversight of the above.
Language:English
Score: 1020660.4
-
https://www.un.org/esa/ffd/wp-...sed-revision-E-C18-2005-10.pdf
Data Source: un
Fascioliasis should be treated with triclabendazole 10mg/kg administered as a single dose. (...) Paragonimiasis can be treated with triclabendazole 20mg/kg, in two divided doses of 10mg/kg to be administered on the same day, or praziquantel 25mg/kg 3 times a day for 3 days. (...) Recommended treatments and strategies
Disease Recommended drug and dosage Recommended strategy Clonorchiasis and opisthorchiasis Individual case management Praziquantel 25 mg/kg three times daily for 2–-3 consecutive days - Treat all confirmed cases - In endemic areas: treat all suspect cases Preventive chemotherapy Praziquantel 40 mg/kg in single administration - In sub-districts, villages or communities where cases appear to be clustered: treat all residents every 12 months Fascioliasis Individual case management Triclabendazole 10 mg/kg in single administration (a double dose of 20 mg/kg in two divided doses 12-24 hours apart can be administered in case of treatment failure) - Treat all confirmed cases - In endemic areas: treat all suspect cases Preventive chemotherapy Triclabendazole 10 mg/kg in single administration – In sub-districts, villages or communities where cases of fascioliasis appear to be clustered: treat all school-age children (5–14 years) or all residents, every 12 months Paragonimiasis Individual case management Triclabendazole: – 2 x 10 mg/kg in the same day or Praziquantel: – 25 mg/kg three times daily for three days - Treat all confirmed cases - In endemic areas: treat all suspect cases Preventive chemotherapy Triclabendazole: – 20 mg/kg in single administration - In sub-districts, villages or communities where cases of paragonimiasis appear to be clustered: treat all residents every 12 months
Our work
Supporting countries in their foodborne trematodiases control efforts
WHO promotes the inclusion of foodborne trematodiases among the targets of preventive chemotherapy interventions.
Language:English
Score: 1018480.7
-
https://www.who.int/news-room/...foodborne-trematode-infections
Data Source: un
Identify and communicate to the relevant focal points any relavent access protocols
(including any relevant requirements and constraints) that are in place at the Treating Medical Facility in which patients are undergoing treatment.
2
iii. (...) Liaise daily with the Treating Medical Facility to maintain a current overview of
the status of COVID-19 patients; ii. (...) Ensure that any non-medical needs of the COVID-19 patient are communicated to the Patient Focal Point and are as far as is possible, being met;
iv. Convey any administrative or financial queries from the Treating Medical Facility to the Patient Focal Point, or in the case of financial queries to Cigna as appropriate;
v.
Language:English
Score: 1018123.2
-
https://www.un.org/sites/un2.u...st-medevac_support_process.pdf
Data Source: un
Identify and communicate to the relevant focal points any relevant access protocols (including any requirements and constraints) that are in place at the Treating Medical Facility in which patients are undergoing treatment.
2
iii. (...) Liaise daily with the Treating Medical Facility to maintain a current overview of the
status of COVID-19 patients; ii. (...) Ensure that any non-medical needs of the COVID-19 patient are communicated to
the Patient Focal Point and are as far as is possible, being met; iv. Convey any administrative or financial queries from the Treating Medical Facility to
the Patient Focal Point, or in the case of financial queries to Cigna as appropriate; v.
Language:English
Score: 1018123.2
-
https://www.un.org/sites/un2.u...st-medevac_support_process.pdf
Data Source: un
